City of Hope Elects Award-Winning Visionary to Board of Directors

Phil Fasano will add thought leadership in technological innovation
and business strategy.


DUARTE, Calif.–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/CityofHope?src=hash” target=”_blank”gt;#CityofHopelt;/agt;–City of Hope today announced the induction of Phil Fasano, a Fortune 100
business strategy expert, to its board of directors.

“Phil Fasano has an impressive track record in enterprise digital
strategies and technology innovation,” said Robert
W. Stone
, president and CEO of City of Hope, a world-renowned
independent research and treatment center for cancer, diabetes and other
life-threatening diseases. “He shares our commitment to using
leading-edge information technology to advance scientific innovation and
deliver personalized medicine to patients.”

Fasano, CEO of strategic advisory and consulting firm Bay Advisors LLC,
brings more than two decades of experience in the financial services,
technology, insurance and health care industries. He is an influential
voice in the push to evolve how companies create, market and use
technologies. His advisory and board relationships include Zenefits,
Onclave Networks, Innovaccer, Domo, Open Data Group, Virtual Rehab,
NeoEyed, Emirates Airlines and Genpact.

Prior to founding his consultant firm, Fasano was the first global chief
information officer and executive vice president at the Fortune 100
global insurance company American International Group (AIG), where he
guided technology strategy, capabilities and operations for more than
60,000 employees in 120 countries. Fasano has also been the CIO and
executive vice president of Kaiser Permanente, where he implemented
electronic medical record systems, activated digital mobile applications
and transformed the organization into a digital health care delivery
system.

Fasano has a master of business administration from Long Island
University and a bachelor’s degree in computer science from the New York
Institute of Technology, where he now serves on the board of trustees.

About City of Hope

City of Hope is an independent biomedical research and treatment center
for cancer, diabetes and other life-threatening diseases. Founded in
1913, City of Hope is a leader in bone
marrow transplantation
and immunotherapy such as CAR
T cell therapy
. City of Hope’s translational research and
personalized treatment protocols advance care throughout the world.
Human synthetic insulin and numerous
breakthrough cancer drugs
are based on technology developed at the
institution. A National Cancer Institute-designated comprehensive cancer
center and a founding member of the National Comprehensive Cancer
Network, City of Hope is ranked one of America’s “Best Hospitals” in
cancer by U.S. News & World Report. Its main campus is
located near Los Angeles, with additional
locations
throughout Southern California. For more information about City
of Hope
, follow us on Facebook,
Twitter,
YouTube
or Instagram.

Contacts

Zen Vuong
626-409-9367
zvuong@coh.org

error: Content is protected !!